Language
![Dolutegravir sodium; (4R,12aS)-N-[(2,4-Difluorophenyl) methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-](https://eimg.pharmasources.com/image/20250312/IKsR24pPkSTr0GsZu1IlvmcZmveuOYsvxe9bngAn.jpg!371)
Grade: Pharmaceutical Grade
Factory Location: Zone B, Innovation Avenue, Taihe Industrial Park, Anhui Province, China
Main Sales Markets: Eastern Europe,Asia,Middle East,Africa
Contract Manufacturing: CRO,CMO
Sample Provided: yes
Payment Terms: T/T, D/P, D/A and L/C
It is one of Disease-Modifying Anti-Rheumatic Drugs.
